IXICO Plc
IXI:LN
Latest Coverage
Overview
Company Profile
Since 2004, we have been dedicated to delivering insights in neuroscience. Our mission is to transform the advancement of new therapies for neurological diseases through the application of medical image analysis, bringing safe and effective treatment to patients sooner. We are committed to advancing imaging biomarkers in CNS therapeutic areas such as Huntington’s disease, Parkinson’s disease and Alzheimer’s disease.
Jul 17, 2025
Jul 17, 2025
May 20, 2025
Apr 22, 2025
Feb 10, 2025
Jan 20, 2025
Jan 6, 2025
Dec 4, 2024
Dec 4, 2024
Classification
Financials
News & Media
Latest Coverage
Corporate
Board of Directors
Bram Goorden
Chief Executive Officer
Bram has over 20 years of leadership in BioPharma and precision medicine. He held C-level roles at Eagle Genomics and SOPHiA Genetics, enhancing platform innovation and US presence. As VP at Foundation Medicine, he expanded its global precision medicine platform. As CEO of Prometheus Laboratories, he integrated it into Nestle Health Science and served as Head of Brain Health. Earlier, he held senior roles at UCB Pharma and Eli Lilly, launching CNS medicines globally. Bram’s board experience includes Mantis Photonics and Cerecin Inc. He is passionate about patient care and values diverse teams. His strategic vision and leadership have consistently driven growth and shareholder value.
Grant Nash
Chief Financial Officer & Company Secretary
Grant has worked in the life sciences sector for over 20 years. In his executive director role, Grant leads the Company's Finance, Legal and IT functions. Grant joined IXICO from UK Biobank, an international health research data resource, where he had been Finance Director since 2014. Previous to this, he qualified as a Chartered Accountant at PwC and was SVP Finance at Evotec, the early stage drug discovery CRO. Grant is a member of the Share Transaction Committee and also acts as Secretary to the Board and its subcommittees.
Robin Wolz, PhD
Chief Scientific Officer
Robin has over 15 years of experience in the development of innovative analytics solutions in healthcare with a focus on imaging technology. Prior to IXICO, Robin held different roles at Philips in the Research and Diagnostic X-Ray divisions. Robin holds a PhD in medical imaging and computer science from Imperial College London, focused on early detection of Alzheimer's disease. He is the co-author of more than 100 publications and holds multiple patents in the field of medical imaging and AI data analytics.